14 stocks that are likely to gain from FTSE’s rebalancing on Friday

14 stocks that are likely to gain from FTSE’s rebalancing on Friday

MUMBAI: Stocks such as Mindtree, Varun Beverages, Hindustan Aeronautics, Honeywell Automation, Astral Poly Technik and Apollo Hospitals among others could advance on Friday as index provider FTSE is set to include them in its midcap index. These stocks are likely to see an inflows between $20 million and $80 million on Friday. Indian equities could … Read more

MTAR Tech IPO opens on Wednesday. What you should know before subscribing

MTAR Tech IPO opens on Wednesday. What you should know before subscribing

ET Intelligence Group: Hyderabad based MTAR Technologies plans to raise Rs 124 crore by issuing fresh equity shares and another Rs 473 crore by selling a portion of existing shares. The company caters to nuclear, defence, and space research sectors. Given the strength of its products and solutions portfolio, increasing opportunities in the renewable energy, … Read more

Blockbuster Q3 gives L&T “problem of plenty” due to order inflows: Key takeaways

Blockbuster Q3 gives L&T “problem of plenty” due to order inflows: Key takeaways

MUMBAI: Larsen & Toubro’s blockbuster order inflows and earnings for the quarter ended December has made the company hopeful of the future, a sharp turnaround from the company’s position earlier this financial year when the national lockdown forced it to junk its order inflow and sales growth guidance for the first time in many years. … Read more

Anil Agarwal plans to move $1 bn from listed Vedanta as loans

Anil Agarwal plans to move  bn from listed Vedanta as loans

Vedanta Ltd (VIL) had agreed to provide loans and guarantees worth Rs 7,900 crore to its parent Vedanta Resources (VRL) just months before the launch of a delisting offer for the Indian subsidiary by the London-based VRL. About Rs 2,311 crore of this loan had already been given before the launch of the offer, latest … Read more

Expect pharma stocks to give 15% compounding returns over medium to long-term: Aditya Khemani

Expect pharma stocks to give 15% compounding returns over medium to long-term: Aditya Khemani

We are not positive but neutral when it comes to the construction or infrastructure space, said Fund Manager, MOAMC. Let us take stock of the earnings so far. Post Axis Bank’s moratorium confusion, it seems like the Street has absorbed the earnings well. I cannot comment on individual stocks but if we look at the … Read more